Go to SARS-CoV-2 and SARS-CoV/HIV-1 Computational Models for Covid-19 Vaccine Development
 Maryia Sivec and Roger Cooperman
About
SARS-CoV-2 and SARS-CoV/HIV-1 Computational Models for Covid-19 Vaccine Development  Maryia Sivec and Roger Cooperman
The Sivec-Cooperman models of SARS-CoV-2 and SARS-CoV/HIV-1 genomes demonstrate that HIV-1 develops compensatory mutations that can restore its reduced fitness and outsmart vacine antagonists
Note from the editor

The Sivec-Cooperman models of SARS-CoV-2 and SARS-CoV/HIV-1 genomes demonstrate that HIV-1 develops compensatory mutations that can restore its reduced fitness and outsmart vacine antagonists

Editors
Go to the profile of Roger Cooperman